A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Condition(s):Community-acquired Bacterial PneumoniaLast Updated:December 8, 2023Recruiting